GBA mutations in Parkinson disease: Earlier death but similar neuropathological features

BACKGROUND: Mutations in the glucocerebrosidase (GBA) gene are known to be a risk factor for Parkinson’s disease (PD). Data on clinicopathologic correlation is limited. The purpose of this study was to determine the clinicopathological findings that might distinguish PD cases with and without mutati...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Eur J Neurol
Main Authors: Adler, Charles H., Beach, Thomas G., Shill, Holly A., Caviness, John N., Driver-Dunckley, Erika, Sabbagh, Marwan N., Patel, Akta, Sue, Lucia I., Serrano, Geidy, Jacobson, Sandra A., Davis, Kathryn, Belden, Christine M., Dugger, Brittany N., Paciga, Sara A., Winslow, Ashley R., Hirst, Warren D., Hentz, Joseph G.
Formato: Artigo
Idioma:Inglês
Publicado: 2017
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5657539/
https://ncbi.nlm.nih.gov/pubmed/28834018
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ene.13395
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares